Header Logo

Connection

MICHAEL ITTMANN to Prostate-Specific Antigen

Back to Details
This is a "connection" page, showing publications MICHAEL ITTMANN has written about Prostate-Specific Antigen.
MICHAEL ITTMANN
Connection Strength
0.672
Prostate-Specific Antigen
  1. A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening. Prostate. 2024 May; 84(7):694-705.
    View in: PubMed
    Score: 0.195
  2. Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy. J Mol Diagn. 2013 Mar; 15(2):270-9.
    View in: PubMed
    Score: 0.090
  3. Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression. PLoS One. 2011; 6(6):e21319.
    View in: PubMed
    Score: 0.081
  4. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate. 2003 Apr 01; 55(1):30-8.
    View in: PubMed
    Score: 0.046
  5. Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis. Hum Pathol. 2022 04; 122:84-91.
    View in: PubMed
    Score: 0.042
  6. Neuronal Trans-Differentiation in Prostate Cancer Cells. Prostate. 2016 10; 76(14):1312-25.
    View in: PubMed
    Score: 0.029
  7. Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties. Oncogene. 2016 11 17; 35(46):5963-5976.
    View in: PubMed
    Score: 0.028
  8. Stromal TGF-? signaling induces AR activation in prostate cancer. Oncotarget. 2014 Nov 15; 5(21):10854-69.
    View in: PubMed
    Score: 0.026
  9. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer. Int J Cancer. 2015 Feb 15; 136(4):875-9.
    View in: PubMed
    Score: 0.025
  10. Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort. Ann Clin Lab Sci. 2013; 43(1):11-21.
    View in: PubMed
    Score: 0.022
  11. Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer. J Urol. 2010 Jul; 184(1):149-56.
    View in: PubMed
    Score: 0.019
  12. Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt. Clin Cancer Res. 2008 Nov 15; 14(22):7511-8.
    View in: PubMed
    Score: 0.017
  13. Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis. J Urol. 2007 May; 177(5):1753-8.
    View in: PubMed
    Score: 0.015
  14. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 2005 Sep 01; 65(17):7976-83.
    View in: PubMed
    Score: 0.014
  15. Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers. Int J Cancer. 2005 Feb 20; 113(5):811-8.
    View in: PubMed
    Score: 0.013
  16. In vivo preservation of steroid specificity in CWR22 xenografts having a mutated androgen receptor. Prostate. 2003 Sep 15; 57(1):1-7.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.